Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2025-12-25 @ 9:29 PM
Study NCT ID:
NCT01118351
Status:
TERMINATED
Last Update Posted:
2019-05-01
First Post:
2010-05-05
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder Cancer
Sponsor:
Case Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-10
Start Date Type:
None
Primary Completion Date:
2012-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-09
Completion Date Type:
ACTUAL
First Submit Date:
2010-05-05
First Submit QC Date:
None
Study First Post Date:
2010-05-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-03-13
Results First Submit QC Date:
None
Results First Post Date:
2019-04-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-17
Last Update Post Date:
2019-05-01
Last Update Post Date Type:
ACTUAL